Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubham Mehta

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Intractable & Rare Diseases Research|December 21, 2017
Expanded dengue syndrome in secondary dengue infection: A case of biopsy proven rhabdomyolysis induced acute kidney injury with intracranial and intraorbital bleedsGhazal Tansir, Chhavi Gupta, Shubham Mehta, et al.
Expert Review of Respiratory Medicine|November 19, 2020
Management of COVID-19 from the pulmonologist's perspective: a narrative reviewSanchit Kumar, Shubham Mehta, Nikhil Sarangdhar, et al.
Micromachines|April 26, 2025
Progress in CO<sub>2</sub> Gas Sensing Technologies: Insights into Metal Oxide Nanostructures and Resistance-Based MethodsYash Ughade, Shubham Mehta, Gautam Patel, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 20, 2025
Early Endovascular Intervention in Combination with Medical Therapy versus Medical Therapy Alone in the Initial Management of Patients with Primary Budd-Chiari Syndrome: A Randomized Controlled TrialSagnik Biswas, Shekhar Swaroop, Shubham Mehta, et al.
Journal of Clinical Medicine|February 13, 2025
Immune Checkpoint Inhibitor in Hepatocellular Carcinoma: Response Rates, Adverse Events, and Predictors of ResponseShekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Journal of Clinical and Experimental Hepatology|June 9, 2025
Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk FactorShekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Digestive Diseases and Sciences|October 27, 2025
Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled TrialSagnik Biswas, Shubham Mehta, Shekhar Swaroop, et al.
Digestive Diseases and Sciences|February 28, 2025
Next-Generation Sequencing Identifies Novel Germline Mutations in Patients with Budd-Chiari Syndrome-Associated Hepatocellular CarcinomaSonu Kumar, Sagnik Biswas, Samagra Agarwal, et al.
Journal of Clinical and Experimental Hepatology|January 17, 2025
Safety and Outcomes of an On-Demand Transfusion Strategy Versus Prophylactic Transfusion of Platelets in Patients With Liver Cirrhosis and Severe Thrombocytopenia Undergoing High-Risk Procedures: A <i>Post Hoc</i> Analysis of Two Randomized Controlled TrialsSagnik Biswas, Sanchita Gupta, Shubham Mehta, et al.
Indian Journal of Pathology & Microbiology|January 19, 2023
Gastrointestinal tract involvement in patients with potential celiac disease beyond the small intestine: An early proof with IgA anti-tissue transglutaminase-2 antibody depositsAshish Chauhan, Prasenjit Das, Alka Singh, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Intractable & Rare Diseases Research|December 21, 2017
Expanded dengue syndrome in secondary dengue infection: A case of biopsy proven rhabdomyolysis induced acute kidney injury with intracranial and intraorbital bleedsGhazal Tansir, Chhavi Gupta, Shubham Mehta, et al.
Expert Review of Respiratory Medicine|November 19, 2020
Management of COVID-19 from the pulmonologist's perspective: a narrative reviewSanchit Kumar, Shubham Mehta, Nikhil Sarangdhar, et al.
Micromachines|April 26, 2025
Progress in CO<sub>2</sub> Gas Sensing Technologies: Insights into Metal Oxide Nanostructures and Resistance-Based MethodsYash Ughade, Shubham Mehta, Gautam Patel, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 20, 2025
Early Endovascular Intervention in Combination with Medical Therapy versus Medical Therapy Alone in the Initial Management of Patients with Primary Budd-Chiari Syndrome: A Randomized Controlled TrialSagnik Biswas, Shekhar Swaroop, Shubham Mehta, et al.
Journal of Clinical Medicine|February 13, 2025
Immune Checkpoint Inhibitor in Hepatocellular Carcinoma: Response Rates, Adverse Events, and Predictors of ResponseShekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Journal of Clinical and Experimental Hepatology|June 9, 2025
Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk FactorShekhar Swaroop, Sagnik Biswas, Shubham Mehta, et al.
Digestive Diseases and Sciences|October 27, 2025
Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled TrialSagnik Biswas, Shubham Mehta, Shekhar Swaroop, et al.
Digestive Diseases and Sciences|February 28, 2025
Next-Generation Sequencing Identifies Novel Germline Mutations in Patients with Budd-Chiari Syndrome-Associated Hepatocellular CarcinomaSonu Kumar, Sagnik Biswas, Samagra Agarwal, et al.
Journal of Clinical and Experimental Hepatology|January 17, 2025
Safety and Outcomes of an On-Demand Transfusion Strategy Versus Prophylactic Transfusion of Platelets in Patients With Liver Cirrhosis and Severe Thrombocytopenia Undergoing High-Risk Procedures: A <i>Post Hoc</i> Analysis of Two Randomized Controlled TrialsSagnik Biswas, Sanchita Gupta, Shubham Mehta, et al.
Indian Journal of Pathology & Microbiology|January 19, 2023
Gastrointestinal tract involvement in patients with potential celiac disease beyond the small intestine: An early proof with IgA anti-tissue transglutaminase-2 antibody depositsAshish Chauhan, Prasenjit Das, Alka Singh, et al.
Pageof 4